Literature DB >> 31607514

Assessment of clinical signs associated with adenoviral epidemic keratoconjunctivitis cases in southern Japan between 2011 and 2014.

Koki Aoki1, Gabriel Gonzalez2, Rikutaro Hinokuma3, Nobuyo Yawata4, Masayuki Tsutsumi1, Shigeaki Ohno1, Nobuyoshi Kitaichi5.   

Abstract

Adenoviral epidemic keratoconjunctivitis (EKC) is a major cause of ocular morbidity worldwide and specific antiviral therapies are not available. EKC is primarily caused by Human adenovirus D (HAdV-D) types 8, 37, 53, 54, 56 and 64. Considering the genomic variation in HAdV-D, we hypothesized that clinical signs could be differentiated by virus type. The hypothesis was retrospectively tested with clinical signs recorded from 250 patients with ocular infections visiting an ophthalmological clinic in southern Japan between 2011 and 2014. The results showed that conjunctival opacity, corneal epithelial disorders and pre-auricular lymphadenopathy, were more frequently associated with EKC than other ocular infections. Furthermore, HAdV types 8, 37 and 54, caused corneal complications and longer infections significantly more frequently than infections by types 53 and 56 (P < 0.05). Our descriptive results supported that symptoms severity vary with the infecting type, however, further research is needed to improve diagnosis of EKC.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Clinical signs; Epidemic keratoconjunctivitis; Human adenovirus; Ocular infections

Mesh:

Year:  2019        PMID: 31607514     DOI: 10.1016/j.diagmicrobio.2019.114885

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Multi-parametric evaluation of ocular surface disorders during healing process of viral conjunctivitis.

Authors:  Gozde Sahin Vural; Ozlem Barut Selver; Ali Veral; Melis Palamar
Journal:  Int Ophthalmol       Date:  2021-11-29       Impact factor: 2.031

2.  Pediatric Infections by Human mastadenovirus C Types 2, 89, and a Recombinant Type Detected in Japan between 2011 and 2018.

Authors:  Kenichiro Takahashi; Gabriel Gonzalez; Masaaki Kobayashi; Nozomu Hanaoka; Michael J Carr; Masami Konagaya; Naomi Nojiri; Miki Ogi; Tsuguto Fujimoto
Journal:  Viruses       Date:  2019-12-06       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.